BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 4766552)

  • 1. Some acute hemodynamic effects of large doses of sodium allopurinol in open-chested dogs.
    Ellis CH; Touw KB; Dickerson SW
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):355-67. PubMed ID: 4766552
    [No Abstract]   [Full Text] [Related]  

  • 2. Coronary and systemic hemodynamic effects of diazepam (Valium) in the unanesthetized dog.
    Bloor CM; Leon AS; Walker DE
    Res Commun Chem Pathol Pharmacol; 1973 Nov; 6(3):1043-51. PubMed ID: 4760879
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of indigocarmine on hemodynamics and on coronary perfusion in dogs].
    Patschke D; Gethmann JW; Tarnow J; Weymar A
    Anaesthesist; 1973 Jul; 22(7):305-7. PubMed ID: 4730135
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of vasopressin during haemorrhagic hypotension in the anesthetized dog.
    Ericsson BF
    Acta Chir Scand; 1972; 138(3):227-33. PubMed ID: 5036819
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic and biochemical results following administration of Allopurinol in healthy individuals].
    Sziegoleit W; Taube C; Terhaag B; Förster W
    Z Gesamte Inn Med; 1973 Aug; 28(15):465-6. PubMed ID: 4765560
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of phentolamine on the cardiovascular effects of dopamine in experimental cardiogenic shock.
    Bagwell EE; Daniell HB; Freeman BF
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):197-203. PubMed ID: 4852444
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and coronary hemodynamic effects of perhexiline.
    Rowe GG; Spring DA; Afonso S
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):377-93. PubMed ID: 4921275
    [No Abstract]   [Full Text] [Related]  

  • 9. A new potentially antianginal benzofuran with an amiodarone-like pharmacological profile.
    Charlier R; Bauthier J
    Arzneimittelforschung; 1973 Sep; 23(9):1305-11. PubMed ID: 4801226
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucagon: its mechanism of action on the coronary circulation in the conscious dog.
    Terry B; White FC; Bloor CM
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):383-9. PubMed ID: 5074531
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effects of octapressin on the general and coronary circulation in anesthetized, closed chest dogs].
    Strauer BE; Reploh HD; Cott L; Tauchert M; Bretschneider HJ
    Arztl Forsch; 1969 Jul; 23(7):227-35. PubMed ID: 5820305
    [No Abstract]   [Full Text] [Related]  

  • 12. Coronary circulation systemic resistance and capacitance blood vessels of dogs as affected by BAY a 1040.
    Hirakawa S; Ito H; Kondo Y; Watanabe I; Hiei K
    Arzneimittelforschung; 1972 Feb; 22(2):344-9. PubMed ID: 4623698
    [No Abstract]   [Full Text] [Related]  

  • 13. The systemic and coronary hemodynamic effects of lidoflazine.
    Thomsen JH; Stenlund RR; Corliss RJ; Sialer S; Rowe GG
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):15-23. PubMed ID: 5650324
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].
    Tarnow J; Gethmann JW; Patschke D; Weymar A; Eberlein HJ
    Arzneimittelforschung; 1975; 25(12):1906-10. PubMed ID: 1243661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic and coronary hemodynamic effects of isoproterenol in control animals and those pretreated with a MAO inhibitor (pargyline hydrochloride).
    McKenna DH; Afonso S; Jaramillo CV; Crumpton CW; Rowe GG
    Arch Int Pharmacodyn Ther; 1966 Aug; 162(2):275-82. PubMed ID: 5968511
    [No Abstract]   [Full Text] [Related]  

  • 16. [The effect of N-(n-propyl)-ajmalinium-hydrogentartrate on canine hemodynamics].
    Mertens HM; Schelbert HR; Kreuzer H; Spiller P; Schmiel FK
    Arzneimittelforschung; 1973 May; 23(5):642-5. PubMed ID: 4740203
    [No Abstract]   [Full Text] [Related]  

  • 17. Systemic and coronary vascular effects of the 2- and the 5-mononitrate esters of isosorbide.
    Wendt RL
    J Pharmacol Exp Ther; 1972 Mar; 180(3):732-42. PubMed ID: 4622308
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cardiovascular effects of dimethophrine in the dog].
    Monguzzi G; Romano A; Scrollini F
    G Ital Cardiol; 1973; 3(1):102-11. PubMed ID: 4695015
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic and coronary hemodynamic effects of sodium nitroprusside.
    Rowe GG; Henderson RH
    Am Heart J; 1974 Jan; 87(1):83-7. PubMed ID: 4808762
    [No Abstract]   [Full Text] [Related]  

  • 20. Whole body and regional hemodynamic effects of minoxidil in the conscious dog.
    Humphrey SJ; Zins GR
    J Cardiovasc Pharmacol; 1984; 6(6):979-88. PubMed ID: 6084789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.